Delivery Order SPE2DR25D6035-SPE2DR26FBLDD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) at a ceiling value of $13,135.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract has an ultimate completion date of December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) with a ceiling value of $24,321. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The order is scheduled for completion by December 12, 2025, and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) with a ceiling value of $1,554.35. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by November 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,289.56 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets in quantities of 90 units. This competitively awarded, firm fixed-price delivery order was issued on November 25, 2025, with an ultimate completion date of November 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a ceiling value of $1,867.39. This firm fixed-price delivery order has an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded among...
- The Defense Logistics Agency awarded a $3,671.46 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count bottles). This firm fixed-price delivery order, with completion scheduled for December 3, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) with a ceiling value of $11,133.20. The contract, which is a firm fixed-price delivery order without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This pharmaceutical supply order will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,846.22 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on December 12, 2025, with completion scheduled for December 15, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a $3,261.04 delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count supply) under a firm fixed price contract. The delivery order, issued on December 11, 2025, with completion targeted for December 12, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,143.92 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count bottles) under a firm fixed price contract. This non-competitive delivery order, issued on November 3, 2025, with completion expected by November 4, 2025, represents a small-value pharmaceutical procurement fulfilling federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office...
- SPE2DR25D6035Indefinite Delivery Contract
- SPE2DR25D6035-SPE2DR26FBLDDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,041.08 to AmerisourceBergen Drug Corp on December 13, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a 90-count quantity. This firm fixed-price delivery order, which must be completed by December 15, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills the order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The current award exemplifies the routine pharmaceutical procurement operations conducted through this prime vendor contract, which positions AmerisourceBergen as a critical supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 12/12/25 |